When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Medicare now negotiating price of drug that costs $7,100 in ...

   www.aol.com/medicare-now-negotiating-price-drug...

   The annual list price of Bristol Myers Squibb’s Eliquis, a blood thinner that reduces the risk of stroke, is $7,100 in the US. ... had Medicare pay the same price for certain expensive ...

3. Factbox-Top Medicare drugs headed for price cuts - AOL

   www.aol.com/news/factbox-top-medicare-drugs...

   The Biden administration selected 10 prescription medicines for unprecedented price negotiations by the Medicare health program for older Americans that covers 66 million people. Blood thinner ...

4. Explainer-Why the US is negotiating the price of 10 drugs - AOL

   www.aol.com/news/explainer-why-us-negotiating...

   The U.S. government on Tuesday released a list of 10 prescription medicines that will be subject to the first-ever price negotiations by the Medicare health program that covers Americans aged 65 ...

5. Apixaban - Wikipedia

   en.wikipedia.org/wiki/Apixaban

   In July 2022, the Canadian generic drug company, Apotex Inc., obtained approval for marketing of apixaban. [37] [38] Pfizer reported revenue of US$6.747 billion for Eliquis in 2023. [39] Apixaban is one of ten medications covered by price negotiations in the US under the Inflation Reduction Act.

6. Direct-to-consumer advertising - Wikipedia

   en.wikipedia.org/wiki/Direct-to-consumer_advertising

   Supporters of direct-to-consumer advertising argue that advertisements increase competition which leads to lower prescription drug prices and new development, citing, for instance, that between 1997 and 2001, spending on research and development in the U.S. increased 59% while spending on promoting drugs directly to patients increased 145%.

7. List of largest selling pharmaceutical products - Wikipedia

   en.wikipedia.org/wiki/List_of_largest_selling...

   Drug Trade name Type Main indications Company Sales (USD millions/year) ∆ vs 2014 1 Adalimumab: Humira Biologic Rheumatoid arthritis: AbbVie Inc. 14,012 1,469 2 Ledipasvir/sofosbuvir: Harvoni Small molecule Hepatitis C: Gilead Sciences: 13,864 11,737 3 Etanercept: Enbrel Biologic Rheumatoid arthritis: Amgen. Pfizer. 8,697 4,009 4 Infliximab ...